Safety of the use of Tissucol® Duo S in cardiovascular surgery: retrospective analysis of 2149 patients after coronary artery bypass grafting

European Journal of Cardio-thoracic Surgery

Volumn 32, Issue 4, 2007, Pages 560-566

  Goerler, Heidi ^a   Oppelt, Petra ^a   Abel, Ulrich ^b   Haverich, Axel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Coronary artery bypass grafting; Fibrin glue; Myocardial infarction

Indexed keywords

FIBRIN GLUE; TISSUE ADHESIVE;

ADULT; AGED; ARTICLE; CONFOUNDING VARIABLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EUROPEAN SYSTEM FOR CARDIAC OPERATIVE RISK EVALUATION; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SAFETY; SCORING SYSTEM; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; METHODOLOGY; POSTOPERATIVE COMPLICATION; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

AGED; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; FEMALE; FIBRIN TISSUE ADHESIVE; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TISSUE ADHESIVES; TREATMENT OUTCOME;

EID: 34548439385     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.01.071     Document Type: Article

References (10)

1. Borst H.G., Haverich A., Walterbusch G., and Maatz W. Fibrin adhesive: an important hemostatic adjunct in cardiovascular operations. J Thorac Cardiovasc Surg 84 4 (1982) 548-553
2. Rousou J., Levitsky S., Gonzalez-Lavin L., Cosgrove D., Magilligan D., Weldon C., Hiebert C., Hess P., Joyce L., and Bergsland J. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg 97 2 (1989) 194-203
3. Berguer R., Staerkel R.L., Moore E.E., Moore F.A., Galloway W.B., and Mockus M.B. Warning: fatal reaction to the use of fibrin glue in deep hepatic wounds. Case reports. J Trauma 31 3 (1991) 408-411
4. Scheule A.M., Beierlein W., Wendel H.P., Eckstein F.S., Heinemann M.K., and Ziemer G. Fibrin sealant, aprotinin, and immune response in children undergoing operations for congenital heart disease. J Thorac Cardiovasc Surg 115 4 (1998) 883-889
5. Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., and Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 1 (1999) 9-13
6. Roques F., Michel P., Goldstone A.R., and Nashef S.A. The logistic EuroSCORE. Eur Heart J 24 9 (2003) 881-882
7. Kleinbaum D.G., Kupper L.L., and Muller K.E. Applied regression analysis and other multivariable methods. 2nd ed. (1988), Duxbury Press, Belmont
8. Rothman K.J. Modern Epidemiology (1986), Little, Brown & Co., Boston, Toronto
9. Hosmer D.W., and Lemeshow S. Applied Logistic Regression (1989), Wiley, New York
10. Kjaergard H.K., and Fairbrother J.E. Controlled clinical studies of fibrin sealant in cardiothoracic surgery - a review. Eur J Cardiothorac Surg 10 (1995) 727-733